Quick Answer
NRX Pharmaceuticals, Inc. reported Stockholders Equity of -$15.94 million for fiscal year 2025.
NRX Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$15.94M | +31.4% |
| 2024 | -$23.22M | -97.9% |
| 2023 | -$11.73M | -258.4% |
| 2022 | $7.41M | -64.4% |
| 2021 | $20.81M | +147.5% |
| 2020 | -$43.77M | -803.8% |
| 2019 | -$4.84M | -196.9% |
| 2018 | $5.00M | +0.0% |
| 2017 | $5.00M | — |
| 2017 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.75M | -36.8% | +27.7% |
| June 30, 2025 | -$35.62M | -93.7% | -41.5% |
| March 31, 2025 | -$25.16M | -67.0% | -8.3% |
| December 31, 2024 | -$23.22M | -97.9% | -23.4% |
| September 30, 2024 | -$18.82M | -202.8% | -2.3% |
| June 30, 2024 | -$18.39M | -555.0% | -22.0% |
| March 31, 2024 | -$15.07M | -5206.0% | -28.4% |
| December 31, 2023 | -$11.73M | -258.4% | -88.7% |
- NRX Pharmaceuticals, Inc. showed an increase of +31.4% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from NRX Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: